CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

FDA Launches Expedited IND Pilot, Begins Accepting Applications

RegulatoryPositive
AI Analysis

Summary

The FDA announced the final design of its Expedited Investigational New Drug (IND) Pilot program and has begun accepting applications. This is a routine regulatory initiative to streamline the drug development process.

Importance:4/10
Sentiment:
0.50
FDAINDRegulatoryDrug Development

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 15, 2026 1:53 PM

Read Original